Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

BACKGROUND: Docetaxel and gemcitabine combinations have proven active for the treatment of non-small cell lung cancer (NSCLC). The aim of the present study was to evaluate and compare two treatment schedules, one based on our own preclinical data and the other selected from the literature. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Passardi, Alessandro, Cecconetto, Lorenzo, Dall'Agata, Monia, Dazzi, Claudio, Pasquini, Enzo, Oliverio, Giovanni, Zumaglini, Federica, Zoli, Wainer, Nanni, Oriana, Milandri, Carlo, Frassineti, Giovanni Luca, Amadori, Dino
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583994/
https://www.ncbi.nlm.nih.gov/pubmed/18976450
http://dx.doi.org/10.1186/1479-5876-6-65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583994/
https://www.ncbi.nlm.nih.gov/pubmed/18976450
http://dx.doi.org/10.1186/1479-5876-6-65

Ejemplares similares